MustGrow Biologics Corp.
MGRO.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 84.90K | 204.70K | -- | -- | 3.46M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 84.90K | 204.70K | -- | -- | 3.46M |
| Cost of Revenue | 111.60K | 63.80K | 42.50K | 12.00K | 69.30K |
| Gross Profit | -26.70K | 140.90K | -42.50K | -12.00K | 3.39M |
| SG&A Expenses | 560.90K | 1.27M | 469.60K | 486.60K | 595.60K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 851.70K | 1.40M | 601.50K | 726.40K | 801.80K |
| Operating Income | -766.80K | -1.20M | -601.50K | -726.40K | 2.66M |
| Income Before Tax | -866.60K | -1.23M | -701.70K | -767.30K | 2.52M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -866.60K | -1.23M | -701.70K | -767.30K | 2.52M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -866.60K | -1.23M | -701.70K | -767.30K | 2.52M |
| EBIT | -766.80K | -1.20M | -601.50K | -726.40K | 2.66M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.02 | -0.02 | -0.01 | -0.01 | 0.05 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | 0.03 |
| EPS Diluted | -0.02 | -0.02 | -0.01 | -0.01 | 0.05 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | 0.03 |
| Average Basic Shares Outstanding | 51.64M | 51.64M | 51.64M | 51.46M | 50.32M |
| Average Diluted Shares Outstanding | 51.64M | 51.64M | 51.64M | 51.46M | 50.32M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |